ArticleBiochemical and biophysical research communications2025
Aquaporin 5 transfer via MDA-MB-231 cell extracellular vesicles increases recipient endothelial cell invasion.
Article in Biochemical and biophysical research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Multifunctional Roles of Aquaporins in Tumors: Focusing on Metabolism, Migration, and Regulation of the Tumor Microenvironment.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Aquaporin 5 (AQP5), a water channel protein, is a known promoter of cancer metastasis, primarily through its role in enhancing cancer cell motility and invasion. While this function has been studied extensively in cancer cells themselves, the contribution of AQP5 to the behavior of other cells in the tumor microenvironment, particularly endothelial cells, remains less understood. Prior studies have linked secreted signals from cancer cells with higher AQP5 expression to increased endothelial angiogenic capacity, a key driver of metastasis. Separately, metastasis-associated proteins have been shown to transfer from cancer to endothelial cells via extracellular vesicles (EVs), promoting angiogenesis. In this study, we investigated whether AQP5-containing EVs influence endothelial cell behavior. We found that EVs derived from cancer cells with high AQP5 expression significantly enhanced the invasive capacity of recipient endothelial cells, a process essential to angiogenesis. These findings provide the first evidence that transfer of the prometastatic protein AQP5 via EVs can modulate endothelial cell function, highlighting a novel mechanism by which cancer cells manipulate their microenvironment to support metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.